[go: up one dir, main page]

MY152276A - Synthesis of morphine-6-glucuronide or one of the derivatives thereof - Google Patents

Synthesis of morphine-6-glucuronide or one of the derivatives thereof

Info

Publication number
MY152276A
MY152276A MYPI20112601A MY152276A MY 152276 A MY152276 A MY 152276A MY PI20112601 A MYPI20112601 A MY PI20112601A MY 152276 A MY152276 A MY 152276A
Authority
MY
Malaysia
Prior art keywords
group
glucuronide
derivatives
morphine
reacting
Prior art date
Application number
Inventor
Alain Dlubala
Isabelle Ripoche
Claire Trecant
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MY152276A publication Critical patent/MY152276A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

THE INVENTION RELATES TO A METHOD FOR PREPARING MORPHINE-6-GLUCURONIDE OR ONE OF THE DERIVATIVES THEREOF, COMPRISING THE FOLLOWING STEPS: (I) REACTING A COMPOUND HAVING FORMULA (I), WHEREIN R1 REPRESENTS A CARBONYL GROUP, COR5CO OR S02R6S02 WITH A GLUCURONIC ACID DERIVATIVE HAVING FORMULA (II) WHEREIN PG REPRESENTS AN ACETYL, ISOBUTYRYL, BENZOYL OR PIVALOYL GROUP, X REPRESENTS A TRIHALOGENOACETAMIDATE GROUP AND R4 REPRESENTS A (C1 ?C4)ALKYLCARBOXYLATE GROUP,IN THE PRESENCE OF AN AROMATIC SOLVENT AND TRIFLUOROMETHANESULFONYL OF TRIMETHYLSILANE; (II) REACTING THE PRODUCT OBTAINED IN STEP (I) WITH A STRONG BASIC AGENT; AND, SUBSEQUENTLY, (III) RECOVERING THE PRODUCT OBTAINED IN STEP (II).
MYPI20112601 2008-12-10 2009-12-08 Synthesis of morphine-6-glucuronide or one of the derivatives thereof MY152276A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806948A FR2939436B1 (en) 2008-12-10 2008-12-10 SYNTHESIS OF MORPHINE-6-GLUCURONIDE OR ONE OF ITS DERIVATIVES

Publications (1)

Publication Number Publication Date
MY152276A true MY152276A (en) 2014-09-15

Family

ID=40996840

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20112601 MY152276A (en) 2008-12-10 2009-12-08 Synthesis of morphine-6-glucuronide or one of the derivatives thereof

Country Status (30)

Country Link
US (1) US8258298B2 (en)
EP (1) EP2376496B1 (en)
JP (1) JP5619768B2 (en)
KR (1) KR20110091534A (en)
CN (1) CN102307876B (en)
AR (1) AR074513A1 (en)
AU (1) AU2009326906B2 (en)
BR (1) BRPI0923238A2 (en)
CA (1) CA2746428A1 (en)
CL (1) CL2011001398A1 (en)
CO (1) CO6390060A2 (en)
CR (1) CR20110307A (en)
EA (1) EA201170790A1 (en)
EC (1) ECSP11011100A (en)
ES (1) ES2470666T3 (en)
FR (1) FR2939436B1 (en)
HN (1) HN2011001597A (en)
IL (1) IL213379A0 (en)
MA (1) MA32950B1 (en)
MX (1) MX337925B (en)
MY (1) MY152276A (en)
NI (1) NI201100116A (en)
NZ (1) NZ593342A (en)
PE (1) PE20110836A1 (en)
SG (1) SG172069A1 (en)
TN (1) TN2011000243A1 (en)
TW (1) TW201033218A (en)
UA (1) UA103643C2 (en)
WO (1) WO2010067007A2 (en)
ZA (1) ZA201104657B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10799496B2 (en) 2018-07-13 2020-10-13 Alkermes Pharma Ireland Limited Naphthylenyl compounds for long-acting injectable compositions and related methods
WO2020012245A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
US10975099B2 (en) 2018-11-05 2021-04-13 Alkermes Pharma Ireland Limited Thiophene compounds for long-acting injectable compositions and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) * 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
ATE242257T1 (en) 1997-04-14 2003-06-15 Ufc Ltd MORPHINE DERIVATIVES
CA2332974C (en) * 1998-06-06 2009-03-10 Cenes Limited Morphine-6-glucuronide synthesis
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
ATE506064T1 (en) * 2001-06-05 2011-05-15 Control Delivery Systems AALGESICS WITH DELAYED RELEASE
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
BR0308567A (en) * 2002-03-19 2007-01-09 Michael Holick apomorphine glycoside and orthoester glycoside derivatives, analogs, and their uses
FR2864082B1 (en) 2003-12-22 2006-03-10 Synt Em NEW MORPHINE-6-GLUCURONIDE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF PAIN

Also Published As

Publication number Publication date
EP2376496B1 (en) 2014-03-12
JP5619768B2 (en) 2014-11-05
UA103643C2 (en) 2013-11-11
ECSP11011100A (en) 2011-07-29
MX337925B (en) 2016-03-28
CR20110307A (en) 2011-09-21
CA2746428A1 (en) 2010-06-17
CN102307876A (en) 2012-01-04
NZ593342A (en) 2013-07-26
ZA201104657B (en) 2012-09-26
FR2939436A1 (en) 2010-06-11
AR074513A1 (en) 2011-01-19
ES2470666T3 (en) 2014-06-24
IL213379A0 (en) 2011-07-31
US8258298B2 (en) 2012-09-04
TW201033218A (en) 2010-09-16
HN2011001597A (en) 2013-09-09
MA32950B1 (en) 2012-01-02
MX2011006264A (en) 2011-11-04
AU2009326906A1 (en) 2011-06-30
KR20110091534A (en) 2011-08-11
BRPI0923238A2 (en) 2016-01-26
CN102307876B (en) 2014-12-10
WO2010067007A2 (en) 2010-06-17
SG172069A1 (en) 2011-07-28
US20110275820A1 (en) 2011-11-10
AU2009326906B2 (en) 2016-05-26
EP2376496A2 (en) 2011-10-19
WO2010067007A3 (en) 2011-07-07
CO6390060A2 (en) 2012-02-29
EA201170790A1 (en) 2011-12-30
CL2011001398A1 (en) 2011-10-28
NI201100116A (en) 2011-12-14
JP2012511551A (en) 2012-05-24
TN2011000243A1 (en) 2012-12-17
HK1163096A1 (en) 2012-09-07
FR2939436B1 (en) 2010-12-17
PE20110836A1 (en) 2011-11-25

Similar Documents

Publication Publication Date Title
WO2008022777A8 (en) Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
WO2010111280A8 (en) Functional polyisobutylene based macromonomers and methods for making and using the same
WO2007092641A3 (en) Method for substituted 1h-imidazo[4,5-c]pyridines
WO2010008847A3 (en) Pi3k/m tor inhibitors
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
WO2009122436A3 (en) An improved process for the preparation of morphinane analogues
WO2009090251A3 (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives
HK1258915A1 (en) Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
WO2009154754A3 (en) Synthesis of deuterated morpholine derivatives
WO2009083532A3 (en) Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
MY150280A (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
MY152276A (en) Synthesis of morphine-6-glucuronide or one of the derivatives thereof
WO2009135598A8 (en) Process for preparing substituted biphenylanilides
WO2008110908A8 (en) Method for preparing hydroxytyrosol derivatives and of hydroxytyrosol
WO2008145673A3 (en) Method for the production of 4-formylaminopiperidine derivatives
WO2007127479A3 (en) Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof
WO2006133397A3 (en) Process for the synthesis of triazoles
WO2008092583A3 (en) Method for producing dihalo acetoacetic alkyl esters
WO2007107345A3 (en) PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
WO2007085651A8 (en) Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds
WO2008017020A3 (en) Process for preparing proton pump inhibitors
WO2010022033A3 (en) Therapeutic substituted pyrroles
TW200740763A (en) A method for preparing 5-hydroxy-1-alkyl pyrazole derivatives